T2 maps were assessed as a potential marker for the long-term follow-up of the patients with cartilage lesions ICRS Grade I-II in five time points (baseline, 8 days, 3, 6 and 12 months). For the T2 mapping, a 3D triple echo steady state sequence which is capable of delivering high quality high-resolved T2 maps at ultra-high field MRI was used. We observed a significant decrease in T2 values at 3T over time in superficial zone of the cartilage defect. There was no statistically significant change at 7T. T2 mapping could be used in the future as a good alternative to cartilage biopsies in clinical trials on new therapies aimed at cartilage regeneration.